Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.398ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.163ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.3 (Theta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.60ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.6.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.45ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.31ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.15 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.21ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.3 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.2 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
M.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.82 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.30ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.23.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.466.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.213ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.56 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.39.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.91.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.4.14 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.359ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.66ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.485ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.73ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.112.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Q.8 (Alpha)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used